Search

everythinglearnresearchcommunity

for

Search:↓

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Hair loss is a common side effect of hormone treatments for cancer.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Angelica gigas Nakai root extracts may help with cancer, pain, memory loss, and metabolic issues.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

New therapies for rare skin diseases show promise but need more research.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

Personalized treatment is crucial for effectively managing benign prostatic hyperplasia (BPH).

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

New antiscarring strategies show promise, including drugs, stem cells, and improved surgical techniques.

Helmet-like device safely increases hair density for people with hair loss.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

The mesenchymal stem cell secretome may effectively treat various diseases as an alternative to traditional stem cell therapies.

Olive oil compounds may help prevent cancer in animals, but human results are mixed.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Doctors need more training in skin cancer screening, a new treatment is effective for a skin condition, better diagnosis methods for skin cancer are available, hair loss in women may be linked to hormones and cholesterol, certain skin care products might cause hair loss, babies' skin gets weaker after birth, and a gene mutation might be linked to eczema.

The treatment effectively promoted hair growth with minimal side effects.